Page 1 of 35 - Food and Drug Administration
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761055s014lbl.pdf
DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 . RECENT MAJOR CHANGES _____ Indications and Usage, Atopic Dermatitis (1.1) 03/2019 Indications and Usage, Asthma (1.2) 10/2018 Indications and Usage, CRSwNP (1.3) 06/2019
DA: 90 PA: 67 MOZ Rank: 14